CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Brimonidine tartrate/timolol maleate

Last Updated: December 15, 2003
Result type: Reports
Project Number: SR0001-000
Product Line: Reimbursement Review

Generic Name: Brimonidine tartrate/timolol maleate

Brand Name: Combigan Ophthalmic Solution

Manufacturer: Allergan Canada Inc.

Therapeutic Area: Glaucoma

Indications: Glaucoma

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 27, 2004

Recommendation Type: List with clinical criteria and/or conditions